Nimbus Testimonial

Innovaderm is proud of its partnership with Nimbus Therapeutics for an investigational oral TYK2 inhibitor, in a Phase 2b trial for patients with moderate-to-severe psoriasis.

Innovaderm’s reputed teams once again proved their expertise throughout the whole project, from the study design all the way to the trial reports, under tight timelines.

“There are many CRO partners out there, but Innovaderm stands out among them as a dedicated, committed partner to their sponsors.” Gabrielle Poirier, Nimbus Therapeutics.

Let our satisfied clients detail our proficiency in managing dermatology clinical trials:


Contact us


Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.